The hypoxia-inducible factor (HIF) pathway as a target for prevention and treatment of clinical manifestations.
Kietzmann
Thomas
T
D051784:Aryl Hydrocarbon Receptor Nuclear Translocator / Q000378:metabolism*; D016503:Drug Delivery Systems; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology
C497442:HIF1A protein, human; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D051784:Aryl Hydrocarbon Receptor Nuclear Translocator